Pembroke Management LTD Has $18.35 Million Holdings in Cellebrite DI Ltd. (NASDAQ:CLBT)

Pembroke Management LTD raised its holdings in shares of Cellebrite DI Ltd. (NASDAQ:CLBT) by 104.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,535,726 shares of the company’s stock after buying an additional 786,310 shares during the quarter. Cellebrite DI comprises 2.5% of Pembroke Management LTD’s investment portfolio, making the stock its 15th largest holding. Pembroke Management LTD owned approximately 0.75% of Cellebrite DI worth $18,352,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of CLBT. Parallel Advisors LLC raised its stake in shares of Cellebrite DI by 75.0% in the fourth quarter. Parallel Advisors LLC now owns 3,500 shares of the company’s stock valued at $30,000 after purchasing an additional 1,500 shares in the last quarter. Quarry LP acquired a new position in Cellebrite DI during the fourth quarter worth $36,000. nVerses Capital LLC acquired a new position in Cellebrite DI during the second quarter worth $103,000. Central Asset Investments & Management Holdings HK Ltd acquired a new position in Cellebrite DI during the fourth quarter worth $113,000. Finally, Hennessy Advisors Inc. acquired a new position in Cellebrite DI during the fourth quarter worth $131,000. 45.88% of the stock is currently owned by institutional investors and hedge funds.

Cellebrite DI Trading Up 0.6 %

Cellebrite DI stock traded up $0.10 during mid-day trading on Monday, hitting $17.06. The stock had a trading volume of 1,500,800 shares, compared to its average volume of 1,150,401. The stock has a 50-day simple moving average of $13.62 and a two-hundred day simple moving average of $12.11. The stock has a market capitalization of $3.51 billion, a PE ratio of -29.41, a P/E/G ratio of 2.35 and a beta of 1.50. Cellebrite DI Ltd. has a 12 month low of $6.36 and a 12 month high of $17.48.

Cellebrite DI (NASDAQ:CLBT) last issued its earnings results on Thursday, August 15th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.08 by $0.02. Cellebrite DI had a positive return on equity of 5,902.06% and a negative net margin of 28.51%. The firm had revenue of $95.70 million for the quarter, compared to analysts’ expectations of $91.94 million. During the same quarter last year, the business earned $0.05 earnings per share. The company’s revenue was up 24.8% compared to the same quarter last year. Sell-side analysts expect that Cellebrite DI Ltd. will post 0.31 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research firms have issued reports on CLBT. JPMorgan Chase & Co. increased their price objective on Cellebrite DI from $14.00 to $15.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 14th. Needham & Company LLC increased their target price on Cellebrite DI from $14.00 to $17.00 and gave the stock a “buy” rating in a report on Friday, August 16th. Deutsche Bank Aktiengesellschaft increased their target price on Cellebrite DI from $15.00 to $18.00 and gave the stock a “buy” rating in a report on Friday, August 16th. Bank of America increased their target price on Cellebrite DI from $13.00 to $17.00 and gave the stock a “buy” rating in a report on Friday, August 16th. Finally, Craig Hallum increased their target price on Cellebrite DI from $16.00 to $20.00 and gave the stock a “buy” rating in a report on Friday, August 16th. Seven research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $17.33.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.